CXCR4-Using HIV Type 1 Variants Are More Commonly Found in Peripheral Blood Mononuclear Cell DNA Than in Plasma RNA

被引:46
作者
Verhofstede, Chris [1 ]
Vandekerckhove, Linos [2 ]
Van Eygen, Veerle [3 ]
Demecheleer, Els [1 ]
Vandenbroucke, Ina [3 ]
Winters, Bart [3 ]
Plum, Jean [1 ]
Vogelaers, Dirk [2 ]
Stuyver, Lieven [3 ]
机构
[1] Univ Ghent, Aids Reference Lab, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Aids Reference Ctr, B-9000 Ghent, Belgium
[3] Virco, Mechelen, Belgium
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CORECEPTOR USAGE; REPLICATIVE CAPACITY; BIOINFORMATIC TOOLS; DISEASE PROGRESSION; VIRAL ENTRY; V3; REGION; PHENOTYPE; ZIDOVUDINE; POPULATION;
D O I
10.1097/QAI.0b013e31819118fa
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To compare the distribution of R5-like and X4-like HIV-1 envelope sequences in plasma and peripheral blood mononuclear cell (PBMC). Methods: Clonal sequencing of the HIV-1 glycoprotein 120 region was performed on PBMC DNA and plasma RNA of 11 HIV-1 subtype B-infected patients with high probability of carrying X4 virus. Coreceptor use was predicted using the position-specific scoring matrix (PSSM). Results: A total of 330 and 427 clonal envelope sequences were obtained from PBMC and plasma, respectively. PSSM interpretation revealed the presence of a mixture of predicted X4 and R5 sequences in 10 patients and pure R5 sequences in 1. The X4 sequences were significantly more represented in PBMC (with an average of 52.2% of the clonal proviral sequences scored X4) compared with plasma (19.7% X4 sequences) (P < 0.0001). At the single patient level, the higher representation of X4 sequences in PBMC reached statistical significance (P < 0.002) in 6 individuals. Conclusions: Mixtures of X4 and R5 sequences with highly divergent PSSM scores are present in both plasma and PBMC, but a shift toward a more abundant representation of X4-like PSSM scores in PBMC-derived DNA was apparent. Additional studies are needed to evaluate the clinical importance of these findings with regard to tropism prediction and the use of CCR5 anatagonists.
引用
收藏
页码:126 / 136
页数:11
相关论文
共 45 条
[1]   The role of HIV type 1 phenotype and genotype in long-term responders to zidovudine therapy [J].
Angarano, G ;
Monno, L ;
Vivirito, MC ;
Appice, A ;
Romanelli, C ;
Giannelli, A ;
LaGrasta, L ;
Fracasso, C ;
Fiore, JR ;
Milazzo, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (11) :969-975
[2]  
ASJO B, 1986, LANCET, V2, P660
[3]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[4]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[5]   Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient [J].
Bunnik, Evelien M. ;
Quakkelaar, Esther D. ;
van Nuenen, Ad C. ;
Boeser-Nummink, Brigitte ;
Schuitemaker, Hanneke .
JOURNAL OF VIROLOGY, 2007, 81 (02) :525-531
[6]   Virus phenotype switching and disease progression in HIV-1 infection [J].
Callaway, DS ;
Ribeiro, RM ;
Nowak, MA .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 266 (1437) :2523-2530
[7]   BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[8]   IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS SUBTYPES WITH DISTINCT PATTERNS OF SENSITIVITY TO SERUM NEUTRALIZATION [J].
CHENGMAYER, C ;
HOMSY, J ;
EVANS, LA ;
LEVY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2815-2819
[9]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[10]   SYNCYTIUM-INDUCING (SI) PHENOTYPE SUPPRESSION AT SEROCONVERSION AFTER INTRAMUSCULAR INOCULATION OF A NON-SYNCYTIUM-INDUCING/SI PHENOTYPICALLY MIXED HUMAN-IMMUNODEFICIENCY-VIRUS POPULATION [J].
CORNELISSEN, M ;
MULDERKAMPINGA, G ;
VEENSTRA, J ;
ZORGDRAGER, F ;
KUIKEN, C ;
HARTMAN, S ;
DEKKER, J ;
VANDERHOEK, L ;
SOL, C ;
COUTINHO, R ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1810-1818